Expert InterviewCORT
Slingshot members are talking to an expert! The topic is:
Speaking With a Payor Expert on the Impact of a Closed Loop Distribution System with a Hub on the Entrance of a Generic in Ultra Orphan Diseases.
Executed on:Jan 30, 2024 4:30 PM EDT
Call Duration:30 minutes
Expert Profile
ExpertBlinded Expert
Institution: Schwarck Healthcare Reimbursement
- Experienced Healthcare Finance Consultant
- Specializes in new drug launch reimbursement support, hub access support and education, specialty drug reimbursement, and complex reimbursement issues
- Knowledgeable about market access, denials, appeals, pre-authorizations, and medical policy navigation.
Interview Goal
This conversation seeks to better understand how payors think about generic drugs when the branded reference drug is part of a closed loop distribution system. Key areas of focus will be:
- What are the impacts on timing of generic conversion in these systems?
- Are Generics responsible for more support if launching a product that has a patient support hub/speciality pharmacy distribution model.
- How effective a strategy to stave off generics is this model historically? Specifically prior to ANDA filing and after FDA approval